ICJIM
Intercontinental Journal of Internal Medicine

The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-0846
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Determining the clarithromycin-resistance of helicobacter pylori in first-line therapy with melting curve analysis
Abstract
Aims: We aimed to determine the usefulness of melting curve analysis with the PCR technique in predicting the primary clarithromycin resistance of H. pylori before antibiotic use.
Methods: 46 H. pylori positive clarithromycin based therapy naïve patients were included in the study. After proving H. pylori positivity with a real-time test, histopathological examination and rapid urease test, patients were treated with clarithromycinbased triple therapy for 14 days. Then patients were underwent a control endoscopy and tissue samples were taken 8 weeks after the initial endoscopy. The presence of H. pylori was investigated by using TaqMan-based real-time PCR and clarithromycin resistance was determined using two different molecular methods:melting curve analysis and DNA sequencing.
Results: In total 18 patients (39.1%) were diagnosed as H. pylori positive on histopathological examination and 26 (56.5%) were diagnosed as H. pylori positive with TaqMan-based PCR, after triple therapy. According to results of melting curve analysis, primary resistance was found in 4 samples before treatment and secondary resistance was found in a different 4 samples after treatment. The DNA analysis showed that 9 patients had primary mutations in the pre-treatment group:4 patients had A2142CA2143G(T), 3 patients had T2182C, and 2 patients had both mutations, and also showed that 6 patients had mutations in the post-treatment group:4 patients had A2142C-A2143G, 2 patients had T2182C mutations.
Conclusion: PCR based melting curve analysis may fail in determining clarithromycin resistance before eradication therapy. Hence, this method may also be used in combination with another molecular method such as DNA sequence analysis for improved detection of clarithromycin resistance.

Keywords : Helicobacter pylori, clarithromycin resistance, triple therapy, melting curve analysis

Download Article


1. Kaplan M, Tanoglu A, Duzenli T, Tozun AN. Helicobacter pyloritreatment in Turkey: Current status and rational treatment options.North Clin Istanb. 2019;7(1):87-94. doi:10.14744/nci.2019.62558
2. Demirci H, Ozturk K, Tanoglu A, et al. Helicobacter pylori ColonizationDensity is an Important Risk Factor for Eradication Therapy. JGastrointestin Liver Dis. 2022;31(2):163-167. doi:10.15403/jgld-4238
3. Kalkanlı Taş S, Kırkık D, Öztürk K, Tanoğlu A. Determination of B- andT- cell epitopes for Helicobacter pylori cagPAI: An in silico approach.Turk J Gastroenterol. 2020;31(10):713-720. doi:10.5152/tjg.2020.19154
4. Song M, Ang TL. Second and third line treatment options forHelicobacter pylori eradication. World J Gastroenterol. 2014;20(6):1517-1528. doi:10.3748/wjg.v20.i6.1517
5. Graham DY, Fischbach L. Helicobacter pylori treatment in the era ofincreasing antibiotic resistance. Gut. 2010;59(8):1143-1153. doi:10.1136/gut.2009.192757
6. Kekilli M, Onal IK, Ocal S, Dogan Z, Tanoglu A. Inefficacy of tripletherapy and comparison of two different bismuth-containing quadrupleregimens as a firstline treatment option for Helicobacter pylori. Saudi JGastroenterol. 2016;22(5):366-369. doi:10.4103/1319-3767.191141
7. Binh TT, Shiota S, Suzuki R, et al. Discovery of novel mutationsfor clarithromycin resistance in Helicobacter pylori by using next-generation sequencing. J Antimicrob Chemother. 2014;69(7):1796-1803.doi:10.1093/jac/dku050
8. Stone GG, Shortridge D, Versalovic J, et al. A PCR-oligonucleotideligation assay to determine the prevalence of 23S rRNA gene mutationsin clarithromycin-resistant Helicobacter pylori. Antimicrob AgentsChemother. 1997;41(3):712-714. doi:10.1128/AAC.41.3.712
9. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequenceanalysis of two copies of a 23S rRNA gene from Helicobacter pylori andassociation of clarithromycin resistance with 23S rRNA mutations.Antimicrob Agents Chemother. 1997;41(12):2621-2628. doi:10.1128/AAC.41.12.2621
10. Kalkanli Tas S, Kirkik D, Tanoglu A, et al. Polymorphisms in Toll-like receptors 1, 2, 5, and 10 are associated with predispositionto Helicobacter pylori infection. Eur J Gastroenterol Hepatol.2020;32(9):1141-1146. doi:10.1097/MEG.0000000000001797
11. Sezikli M, Sirin G, Akkan Cetinkaya Z, Tanoglu A, Guzelbulut F,Bunul F,et al. Comparison of the efficacy of six different Helicobacterpylori eradication regimens: greater than or equal to another. BiomedRes.2018;29:1243-48.
12. Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobialsusceptibility testing. Clin Microbiol Rev. 2007;20(2):280-322. doi:10.1128/CMR.00033-06
13. Marais A, Monteiro L, Occhialini A, Pina M, Lamouliatte H, MégraudF. Direct detection of Helicobacter pylori resistance to macrolides bya polymerase chain reaction/DNA enzyme immunoassay in gastricbiopsy specimens. Gut. 1999;44(4):463-467. doi:10.1136/gut.44.4.463
14. Owen RJ. Molecular testing for antibiotic resistance in Helicobacterpylori. Gut. 2002;50(3):285-289. doi:10.1136/gut.50.3.285
15. Yilmaz O, Demiray E, Tümer S, et al. Detection of Helicobacter pyloriand determination of clarithromycin susceptibility using formalin-fixed, paraffin-embedded gastric biopsy specimens by fluorescence insitu hybridization. Helicobacter. 2007;12(2):136-141. doi:10.1111/j.1523-5378.2007.00483.x
16. Can F, Yilmaz Z, Demirbilek M, et al. Diagnosis of Helicobacterpylori infection and determination of clarithromycin resistance byfluorescence in situ hybridization from formalin-fixed, paraffin-embedded gastric biopsy specimens. Can J Microbiol. 2005;51(7):569-573. doi:10.1139/w05-035
17. Houben MH, van de Beek D, Hensen EF, de Craen AJ, Rauws EA,Tytgat GN. A systematic review of Helicobacter pylori eradicationtherapy--the impact of antimicrobial resistance on eradication rates.Aliment Pharmacol Ther. 1999;13(8):1047-1055. doi:10.1046/j.1365-2036.1999.00555.x
18. Gibson JR, Saunders NA, Burke B, Owen RJ. Novel method for rapiddetermination of clarithromycin sensitivity in Helicobacter pylori. JClin Microbiol. 1999;37(11):3746-3748. doi:10.1128/JCM.37.11.3746-3748.1999
19. Sambrook J, Fritsch EF, Maniatis T. Isolation of DNA from mammaliancells. In: Sambrook J, Fritsch EF, Maniatis T, editors. MolecularCloning: A Laboratory Manual (Vol 1). 2nd ed. New York: Cold SpringHarbor Laboratory Press. 1989; 916-919.
20. Kubar A, Saygun I, Yapar M, Ozdemir A, Slots J. Real-time PCRquantification of cytomegalovirus in aggressive periodontitis lesionsusing TaqMan technology. J Periodontal Res. 2004;39(2):81-86.doi:10.1111/j.1600-0765.2004.00707.x
21. Yapar M, Aydogan H, Pahsa A, et al. Rapid and quantitative detectionof Crimean-Congo hemorrhagic fever virus by one-step real-timereverse transcriptase-PCR. Jpn J Infect Dis. 2005;58(6):358-362.
22. Şahiner F, Kubar A, Yapar M, Şener K, Dede M, Gümral R. Detectionof major HPVs by a new multiplex real-time PCR assay using type-specific primers. J Microbiol Methods. 2014;97:44-50. doi:10.1016/j.mimet.2013.12.012
23. Chen S, Li Y, Yu C. Oligonucleotide microarray: a new rapid methodfor screening the 23S rRNA gene of Helicobacter pylori for singlenucleotide polymorphisms associated with clarithromycin resistance.J Gastroenterol Hepatol. 2008;23(1):126-131. doi:10.1111/j.1440-1746.2007.04900.x
24. Garrido L, Toledo H. Novel genotypes in Helicobacter pylori involvingdomain V of the 23S rRNA gene. Helicobacter. 2007;12(5):505-509.doi:10.1111/j.1523-5378.2007.00506.x
25. Mahachai V, Thong-Ngam D, Noophun P, Tumwasorn S, Kullavanijaya P.Efficacy of clarithromycin-based triple therapy for treating Helicobacterpylori in Thai non-ulcer dyspeptic patients with clarithromycin-resistantstrains. J Med Assoc Thai. 2006;89 Suppl 3:S74-S78.
26. De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistantgenotypes and eradication of Helicobacter pylori. Ann Intern Med.2006;144(2):94-100. doi:10.7326/0003-4819-144-2-200601170-00006
27. Gu Q, Xia HH, Wang JD, et al. Update on clarithromycin resistance inHelicobacter pylori in Hong Kong and its effect on clarithromycin-basedtriple therapy. Digestion. 2006;73(2-3):101-106. doi:10.1159/000094040
28. Aydin A, Onder G, Akarca U, Tekin F, Tuncyurek M, Ilter T.Comparison of 1- and 2-week pantoprazole-based triple therapiesin clarithromycin-sensitive and resistant cases. Eur J Intern Med.2007;18(6):496-500. doi:10.1016/j.ejim.2007.02.018
29. Hu CT, Wu CC, Lin CY, et al. Resistance rate to antibiotics ofHelicobacter pylori isolates in eastern Taiwan. J Gastroenterol Hepatol.2007;22(5):720-723. doi:10.1111/j.1440-1746.2006.04743.x
Article available in :
Volume 1, Issue 2, 2023
Page : 32-36
https://doi.org/10.51271/ICJIM-0007
Article Information
Received : 25 Mar 2023
Accepted : 02 Nis 2023
Published : 29 May 2023
Corresponding Author :

Kemalettin Yılmaz: Lokman Hekim Hospital, Gastroenterology Department, Ankara, TURKEY

[email protected]
Citation : Yılmaz K, Uygun A, Kubar A. Determining the clarithromycin-resistance of Helicobacter pylori in first-line therapy with melting curve analysis. Intercont J Int Med. 2023;1(2):32-36.

Read: 217
Cited: 0
Download : 259
_Footer